Top

Published in:

01-03-2013 | Original Article

Management of distal rectal cancer: results from a national survey

Authors: G. Melotti, E. De Antoni, A. Habr-Gama, A. Minicozzi

Published in: Updates in Surgery | Issue 1/2013

Abstract

Owing to the complexity of distal rectal cancer its management requires a multidisciplinary approach. The diagnosis and the response after neoadjuvant chemoradiotherapy are not easy to assess and therefore the surgical approach is heterogeneous. The purpose of this survey is to evaluate the experiences of members of the Italian Society of Surgery in diagnosis and treatment strategies for rectal cancer and compare it with international practice. A questionnaire was devised comprising 18 questions with 11 sub-items making a total of 29 questions and submitted online to all the 2,500 members of the SIC starting from July 2010. The survey was completed in June 2011. The overall response rate was 17.8 % (444). The majority of the Italian surgeons’ responses were in line with the international consensus reflecting the complex management of distal rectal cancer. Other opinions, especially those on staging, diverge from the common view of MRI being the gold standard in the assessment of loco-regional diffusion of the disease and on the superiority of FDG PET-CT versus CT for systemic staging. The timing for the re-staging and for surgery following neoadjuvant chemoradiotherapy does not reflect the international opinion. Italian surgeons are also exposed to the common difficulties encountered internationally in the management of distal rectal cancer. Probably, the implementation of an Italian rectal cancer registry and of many national and international multicentre studies may improve the management of rectal cancer in Italy.

Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. Cancer J Clin 61(2):69–90

Grassetto G, Marzola MC, Minicozzi A, Al-Nahhas A, Rubello D (2011) F-18 FDG PET/CT in rectal carcinoma: where are we now? Clin Nucl Med 36(10):884–888 (Review)PubMedCrossRef

Murad-Regadas SM, Regadas FS, Rodrigues LV, Crispin FJ, Kenmoti VT, Fernandes GO, Buchen G, Monteiro FC (2011) Criteria for three-dimensional anorectal ultrasound assessment of response to chemoradiotherapy in rectal cancer patients. Colorectal Dis 13(12):1344–1354PubMedCrossRef

Kundel Y, Brenner R, Purim O, Peled N, Idelevich E, Fenig E, Sulkes A, Brenner B (2010) Is local excision after complete pathological response to neoadjuvant chemoradiation for rectal cancer an acceptable treatment option? Dis Colon Rectum 53(12):1624–1631PubMedCrossRef

Habr-Gama A, Perez RO, São Julião GP, Proscurshim I, Gama-Rodrigues J (2011) The need for effective radiosentitizing agents: experience in patients with complete pathological response. Anticancer Drugs 22(4):308–310 (Review)PubMedCrossRef

Gerard JP, Rostom Y, Gal J, Benchimol D, Ortholan C, Aschele C, Levi JM (2012) Can we increase the chance of sphincter saving surgery in rectal cancer with neoadjuvant treatments: lessons from a systematic review of recent randomized trials. Crit Rev Oncol Hematol 81(1):21–28 [Epub 2011 Mar 5]PubMedCrossRef

Habr-Gama A, Perez RO, São Julião GP, Proscurshim I, Nahas SC, Gama-Rodrigues J (2011) Factors affecting management decisions in rectal cancer in clinical practice: results from a national survey. Tech Coloproctol 15(1):45–51 [Epub 2010 Nov 6]PubMedCrossRef

Wynn GR, Bhasin N, Macklin CP, George ML (2010) Complete clinical response to neoadjuvant chemoradiotherapy in patients with rectal cancer: opinions of British and Irish specialists. Colorectal Dis 12(4):327–333 [Epub 2009 Jun 25]PubMedCrossRef

Augestad KM, Lindsetmo RO, Reynolds H, Stulberg J, Senagore A, Champagne B, Heriot AG, Leblanc F, Delaney CP (2011) International trends in surgical treatment of rectal cancer. Am J Surg 201(3):353–357 (discussion 357-8)PubMedCrossRef

10.

Gagliardi G, Pucciarelli S, Asteria CR, Infantino A, Romano G, Cola B, De Nardi P, Brulatti M, Lambertini M, Contessini-Avesani E, Casula G, Coco C, D’Amico D, Selvaggi FF, Eccher C, D’Ambrosio G, Galeotti F, Jovine E, Demma I, Fianchini A, Ambrosino G, Casentino LM, Fiorino M (2010) A nationwide audit of the use of radiotherapy for rectal cancer in Italy. Tech Coloproctol 14(3):229–235 [Epub 2010 Jul 15]PubMedCrossRef

11.

Nugent E, Neary P (2010) Rectal cancer surgery: volume-outcome analysis. Int J Colorectal Dis 25(12):1389–1396 [Epub 2010 Jul 27, Review]PubMedCrossRef

12.

Taylor F, Mangat N, Swift IR, Brown G (2010) Proforma-based reporting in rectal cancer. Cancer Imaging 10 Spec no A:S142–S150PubMedCrossRef

13.

Beets-Tan RG, Beets GL, Vliegen RF, Kessels AG, Van Boven H, De Bruine A, von Meyenfeldt MF, Baeten CG, van Engelshoven JM (2001) Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet 357(9255):497–504PubMedCrossRef

14.

Bamba Y, Itabashi M, Kameoka S (2012) Preoperative evaluation of the depth of anal canal invasion in very low rectal cancer by magnetic resonance imaging and surgical indications for intersphincteric resection. Surg Today 42(4):328–333 [Epub 2011 Nov 11]PubMedCrossRef

15.

Capirci C, Rubello D, Pasini F, Galeotti F, Bianchini E, Del Favero G, Panzavolta R, Crepaldi G, Rampin L, Facci E, Gava M, Banti E, Marano G (2009) The role of dual-time combined 18-fluorodeoxyglucose positron emission tomography and computed tomography in the staging and restaging workup of locally advanced rectal cancer, treated with preoperative chemoradiation therapy and radical surgery. Int J Radiat Oncol Biol Phys 74(5):1461–1469 [Epub 2009 May 4]PubMedCrossRef

16.

Guillem JG, Moore HG, Akhurst T, Klimstra DS, Ruo L, Mazumdar M, Minsky BD, Saltz L, Wong WD, Larson S (2004) Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: a means for determining longterm outcomes of rectal cancer. J Am Coll Surg 199(1):1–7PubMedCrossRef

17.

Janssen MH, Öllers MC, van Stiphout RG, Riedl RG, van den Bogaard J, Buijsen J, Lambin P, Lammering G (2012) PET-based treatment response evaluation in rectal cancer: prediction and validation. Int J Radiat Oncol Biol Phys 82(2):871–876 [Epub 2011 Mar 5]PubMedCrossRef

18.

Shihab OC, Quirke P, Heald RJ, Moran BJ, Brown G (2010) Magnetic resonance imaging-detected lymph nodes close to the mesorectal fascia are rarely a cause of margin involvement after total mesorectal excision. Br J Surg 97(9):1431–1436PubMedCrossRef

19.

Heriot AG, Hicks RJ, Drummond EG, Keck J, Mackay J, Chen F, Kalff V (2004) Does positron emission tomography change management in primary rectal cancer? A prospective assessment. Dis Colon Rectum 47(4):451–458 [Epub 2004 Feb 25]PubMedCrossRef

20.

Gearhart SL, Frassica D, Rosen R, Choti M, Schulick R, Wahl R (2006) Improved staging with pretreatment positron emission tomography/computed tomography in low rectal cancer. Ann Surg Oncol 13(3):397–404 [Epub 2006 Jan 30]PubMedCrossRef

21.

Lambregts DM, Maas M, Bakers FC, Cappendijk VC, Lammering G, Beets GL, Beets-Tan RG (2011) Long-term follow-up features on rectal MRI during a wait-and-see approach after a clinical complete response in patients with rectal cancer treated with chemoradiotherapy. Dis Colon Rectum 54(12):1521–1528PubMedCrossRef

22.

Lambregts DM, Vandecaveye V, Barbaro B, Bakers FC, Lambrecht M, Maas M, Haustermans K, Valentini V, Beets GL, Beets-Tan RG (2011) Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study. Ann Surg Oncol 18(8):2224–2231 [Epub 2011 Feb 23]PubMedCrossRef

23.

Perez RO, Habr-Gama A, Gama-Rodrigues J, Proscurshim I, Julião GP, Lynn P, Ono CR, Campos FG, Silva E Sousa AH Jr Md, Imperiale AR, Nahas SC, Buchpiguel CA (2012) Accuracy of positron emission tomography/computed tomography and clinical assessment in the detection of complete rectal tumor regression after neoadjuvant chemoradiation: long-term results of a prospective trial (National Clinical Trial 00254683). Cancer 118(14):3501–3511

24.

Martellucci J, Scheiterle M, Lorenzi B, Roviello F, Cetta F, Pinto E, Tanzini G (2012) Accuracy of transrectal ultrasound after preoperative radiochemotherapy compared to computed tomography and magnetic resonance in locally advanced rectal cancer. Int J Colorectal Dis 27(7):967–973

25.

Guillem JG, Chessin DB, Shia J, Moore HG, Mazumdar M, Bernard B, Paty PB, Saltz L, Minsky BD, Weiser MR, Temple LK, Cohen AM, Wong WD (2005) Clinical examination following preoperative chemoradiation for rectal cancer is not a reliable surrogate end point. J Clin Oncol 23(15):3475–3479PubMedCrossRef

26.

Kuo LJ, Chiou JF, Tai CJ, Chang CC, Kung CH, Lin SE, Hung CS, Wang W, Tam KW, Lee HC, Liang HH, Chang YJ, Wei PL (2011) Can we predict pathologic complete response before surgery for locally advanced rectal cancer treated with preoperative chemoradiation therapy? Int J Colorectal Dis [Epub ahead of print]

27.

Habr-Gama A, Perez RO, Wynn G, Marks J, Kessler H, Gama-Rodrigues J (2010) Complete clinical response after neoadjuvant chemoradiation therapy for distal rectal cancer: characterization of clinical and endoscopic findings for standardization. Dis Colon Rectum 53(12):1692–1698PubMedCrossRef

28.

Smith FM, Chang KH, Sheahan K, Hyland J, O’Connell PR, Winter DC (2012) The surgical significance of residual mucosal abnormalities in rectal cancer following neoadjuvant chemoradiotherapy. Br J Surg. doi:10.1002/bjs.8700 [Epub ahead of print]

29.

Bökkerink GM, de Graaf EJ, Punt CJ, Nagtegaal ID, Rütten H, Nuyttens JJ, van Meerten E, Doornebosch PG, Tanis PJ, Derksen EJ, Dwarkasing RS, Marijnen CA, Cats A, Tollenaar RA, de Hingh IH, Rutten HJ, van der Schelling GP, Ten Tije AJ, Leijtens JW, Lammering G, Beets GL, Aufenacker TJ, Pronk A, Manusama ER, Hoff C, Bremers AJ, Verhoef C, de Wilt JH (2011) The CARTS study: Chemoradiation therapy for rectal cancer in the distal rectum followed by organ-sparing transanal endoscopic microsurgery. BMC Surg 11(1):34PubMedCrossRef

30.

Petersen S, Hellmich G, von Mildenstein K, Porse G, Ludwig K (2006) Is surgery-only the adequate treatment approach for T2N0 rectal cancer? J Surg Oncol 93(5):350–354PubMedCrossRef

31.

Gérard JP, Azria D, Gourgou-Bourgade S, Martel-Laffay I, Hennequin C, Etienne PL, Vendrely V, François E, de La Roche G, Bouché O, Mirabel X, Denis B, Mineur L, Berdah JF, Mahé MA, Bécouarn Y, Dupuis O, Lledo G, Montoto-Grillot C, Conroy T (2010) Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405–Prodige 2. Clin Oncol 28(10):1638–1644 [Epub 2010 Mar 1]CrossRef

32.

Aschele C, Cionini L, Lonardi S, Pinto C, Cordio S, Rosati G, Artale S, Tagliagambe A, Ambrosini G, Rosetti P, Bonetti A, Negru ME, Tronconi MC, Luppi G, Silvano G, Corsi DC, Bochicchio AM, Chiaulon G, Gallo M, Boni L (2011) Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial. J Clin Oncol 29(20):2773–2780 [Epub 2011 May 23]PubMedCrossRef

33.

Valentini V, Beets-Tan R, Borras JM et al (2008) Evidence and research in rectal cancer. Radiother Oncol 87:449–474PubMedCrossRef

34.

Glynne-Jones R, Anyamene N, Moran B, Harrison M (2012) Neoadjuvant chemotherapy in MRI-staged high-risk rectal cancer in addition to or as an alternative to preoperative chemoradiation? Ann Oncol [Epub ahead of print]

35.

Gérard A, Buyse M, Nordlinger B, Loygue J, Pène F, Kempf P, Bosset JF, Gignoux M, Arnaud JP, Desaive C et al (1988) Preoperative radiotherapy as adjuvant treatment in rectal cancer. Final results of a randomized study of the European Organization for Research and Treatment of Cancer (EORTC). Ann Surg 208(5):606–614PubMedCrossRef

36.

Pettersson D, Holm T, Iversen H, Blomqvist L, Glimelius B, Martling A (2012) Preoperative short-course radiotherapy with delayed surgery in primary rectal cancer. Br J Surg 99(4):577–583. doi:10.1002/bjs.7796 [Epub 2012 Jan 12]PubMedCrossRef

37.

Pettersson D, Cedermark B, Holm T, Radu C, Påhlman L, Glimelius B, Martling A (2010) Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens for rectal cancer. Br J Surg 97(4):580–587PubMedCrossRef

38.

Li JL, Ji JF, Cai Y, Li XF, Li YH, Wu H, Xu B, Dou FY, Li ZY, Bu ZD, Wu AW, Tham IW (2012) Preoperative concomitant boost intensity-modulated radiotherapy with oral capecitabine in locally advanced mid-low rectal cancer: a phase II trial. Radiother Oncol 102(1):4–9 [Epub 2011 Sep 6]PubMedCrossRef

39.

Gasent Blesa JM, Garde Noguera J, Laforga Canales JB, Giner Bosch V, Alberola A, Soler Tortosa M, Peris Godoy M, Sanchez JL, Provencio Pulla M, Alberola Candel V (2012) Phase II trial of concomitant neoadjuvant chemotherapy with oxaliplatin and capecitabine and intensity-modulated radiotherapy (IMRT) in rectal cancer. J Gastrointest Cancer, Feb 28

40.

Kalady MF, de Campos-Lobato LF, Stocchi L, Geisler DP, Dietz D, Lavery IC, Fazio VW (2009) Predictive factors of pathologic complete response after neoadjuvant chemoradiation for rectal cancer. Ann Surg 250(4):582–589

41.

Evans J, Tait D, Swift I, Pennert K, Tekkis P, Wotherspoon A, Chau I, Cunningham D, Brown G (2011) Timing of surgery following preoperative therapy in rectal cancer: the need for a prospective randomized trial? Colon Rectum 54(10):1251–1259CrossRef

42.

Garcia-Aguilar J, Smith DD, Avila K, Bergsland EK, Chu P (2011) Timing of Rectal Cancer Response to Chemoradiation Consortium. Optimal timing of surgery after chemoradiation for advanced rectal cancer: preliminary results of a multicenter, nonrandomized phase II prospective trial. Ann Surg 254(1):97–102PubMedCrossRef

43.

Dhadda AS, Zaitoun AM, Bessell EM (2009) Regression of rectal cancer with radiotherapy with or without concurrent capecitabine–optimising the timing of surgical resection. Clin Oncol (R Coll Radiol) 21(1):23–31 [Epub 2008 Nov 21]CrossRef

44.

de Campos-Lobato LF, Geisler DP, da Luz Moreira A, Stocchi L, Dietz D, Kalady MF (2011) Neoadjuvant therapy for rectal cancer: the impact of longer interval between chemoradiation and surgery. J Gastrointest Surg 15(3):444–450 [Epub 2010 Dec 8]PubMedCrossRef

45.

Garcia-Aguilar J, Shi Q, Thomas CR Jr, Chan E, Cataldo P, Marcet J, Medich D, Pigazzi A, Oommen S, Posner MC (2012) A phase II trial of neoadjuvant chemoradiation and local excision for T2N0 rectal cancer: preliminary results of the ACOSOG Z6041 trial. Ann Surg Oncol 19(2):384–391 [Epub 2011 Jul 14]PubMedCrossRef

46.

Martin ST, Heneghan HM, Winter DC (2012) Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer. Br J Surg. doi:10.1002/bjs.8702

47.

Maas M, Nelemans PJ, Valentini V, Das P et al (2010) Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol 11:835–844PubMedCrossRef

48.

Martin ST, Heneghan HM, Winter DC (2012) Systematic review of outcomes after intersphincteric resection for low rectal cancer. Br J Surg. doi:10.1002/bjs.8677

49.

Lezoche G, Baldarelli M, Guerrieri M, Paganini AM, De Sanctis A, Bartolacci S, Lezoche E (2008) A prospective randomized study with a 5-year minimum follow-up evaluation of transanal endoscopic microsurgery versus laparoscopic total mesorectal excision after neoadjuvant therapy. Surg Endosc 22(2):352–358PubMedCrossRef

50.

Lim L, Chao M, Shapiro J, Millar JL, Kipp D, Rezo A, Fong A, Jones IT, McLaughlin S, Gibbs P (2007) Long-term outcomes of patients with localized rectal cancer treated with chemoradiation or radiotherapy alone because of medical inoperability or patient refusal. Dis Colon Rectum 50(12):2032–2039 [Epub 2007 Sep 26]PubMedCrossRef

51.

Maas M, Beets-Tan RG, Lambregts DM, Lammering G, Nelemans PJ, Engelen SM, van Dam RM, Jansen RL, Sosef M, Leijtens JW, Hulsewé KW, Buijsen J, Beets GL (2011) Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. J Clin Oncol 29(35):4633–4640 [Epub 2011 Nov 7]PubMedCrossRef

52.

Dalton R, Velineni R, Osborne M, Thomas R, Harries S, Gee A, Daniels I (2012) A single centre experience of chemo-radiotherapy for rectal cancer: Is there potential for non-operative management? Colorectal Dis 14(5):567–571

53.

Pietsch AP, Fietkau R, Klautke G, Foitzik T, Klar E (2007) Effect of neoadjuvant chemoradiation on postoperative fecal continence and anal sphincter function in rectal cancer patients. Int J Colorectal Dis 22(11):1311–1317 [Epub 2007 May 12]PubMedCrossRef

54.

Giordano P, Efron J, Vernava AM 3rd, Weiss EG, Nogueras JJ, Wexner SD (2006) Strategies of follow-up for colorectal cancer: a survey of the American Society of Colon and Rectal Surgeons. Tech Coloproctol 10(3):199–207 [Epub 2006 Sep 20]PubMedCrossRef

55.

Asteria CR, Gagliardi G, Pucciarelli S, Romano G, Infantino A, La Torre F, Tonelli F, Martin F, Pulica C, Ripetti V, Diana G, Amicucci G, Carlini M, Sommariva A, Vinciguerra G, Poddie DB, Amato A, Bassi R, Galleano R, Veronese E, Mancini S, Pescio G, Occelli GL, Bracchitta S, Castagnola M, Pontillo T, Cimmino G, Prati U, Vincenti R (2008) Anastomotic leaks after anterior resection for mid and low rectal cancer: survey of the Italian Society of Colorectal Surgery. Tech Coloproctol 12(2):103–110 [Epub 2008 Jun 10]PubMedCrossRef

56.

Ooi K, Frizelle F, Ong E, Faragher I (2012) Current practice in preoperative therapy and surgical management of locally advanced rectal cancer: A bi-national survey. Colorectal Dis 14(7):814–820

Title: Management of distal rectal cancer: results from a national survey
Authors: G. Melotti
E. De Antoni
A. Habr-Gama
A. Minicozzi
Publication date: 01-03-2013
Publisher: Springer Milan
Published in: Updates in Surgery / Issue 1/2013
Print ISSN: 2038-131X
Electronic ISSN: 2038-3312
DOI: https://doi.org/10.1007/s13304-012-0192-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Management of distal rectal cancer: results from a national survey

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2013

Robotic surgery in Italy national survey (2011)

Extra-hepatic intra-abdominal hydatid cyst: which characteristic, compared to the hepatic location?

Heterotopic spleen within the gastric wall mimicking a GIST: report of a case

Impact of laparoscopic Nissen’s fundoplication on response of disease specific symptoms and quality of life

Tryptase-positive mast cells and angiogenesis in keloids: a new possible post-surgical target for prevention

Potential role of cholinesterases to predict short-term outcome after hepatic resection for hepatocellular carcinoma